These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Terminal deoxynucleotidyl transferase in the blastic phase of chronic myelogenous leukemia: an indicator of response to vincristine and prednisone therapy. Tanaka M; Kaneda T; Hirota Y; Yoshida S; Kitajima K Am J Hematol; 1980; 9(3):287-93. PubMed ID: 6940442 [TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid receptor level, terminal deoxynucleotidyl transferase activity and initial responsiveness to prednisone and vincristine in leukemia. Ho AD; Stojakowits S; Pralle H; Dörner M; Hunstein W Klin Wochenschr; 1983 May; 61(9):455-9. PubMed ID: 6575218 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic and prognostic implications of glucocorticoid receptors and terminal deoxynucleotidyl transferase in acute leukemia. Ho AD; Hunstein W; Ganeshaguru K; Hoffbrand AV; Brandeis WE; Denk B Leuk Res; 1982; 6(1):1-8. PubMed ID: 6951099 [TBL] [Abstract][Full Text] [Related]
6. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence. Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737 [TBL] [Abstract][Full Text] [Related]
7. Terminal transferase surveillance of remission bone marrows in childhood acute lymphoblastic leukemia: improved sensitivity with countercurrent centrifugal elutriation. Lauer SJ; Lyman S; Kirchner PA; Gottschall JL; Camitta BM; Casper JT J Clin Lab Immunol; 1985 Jan; 16(1):17-22. PubMed ID: 3856682 [TBL] [Abstract][Full Text] [Related]
14. Terminal deoxynucleotidyl transferase-containing cells in peripheral blood: implications for the surveillance of patients with lymphoblastic leukemia or lymphoma in remission. Froehlich TW; Buchanan GR; Cornet JA; Sartain PA; Smith RG Blood; 1981 Aug; 58(2):214-20. PubMed ID: 7018621 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of cerebrospinal fluid mononuclear cells obtained from children with acute lymphocytic leukemia: advantages of combining cytomorphology and terminal deoxynucleotidyl transferase. Casper JT; Lauer SJ; Kirchner PA; Gottschall JL; Camitta BM Am J Clin Pathol; 1983 Nov; 80(5):666-70. PubMed ID: 6579834 [TBL] [Abstract][Full Text] [Related]
16. Terminal deoxynucleotidyl transferase positive lymphoblastic lymphoma: a study of 15 cases. Long JC; McCaffrey RP; Aisenberg AC; Marks SM; Kung PC Cancer; 1979 Dec; 44(6):2127-39. PubMed ID: 315816 [TBL] [Abstract][Full Text] [Related]
17. Serial observations on terminal deoxynucleotidyl transferase activity and lymphoblast surface markers in acute lymphoblastic leukemia. Coleman MS; Greenwood MF; Hutton JJ; Bollum FJ; Lampkin B; Holland P Cancer Res; 1976 Jan; 36(1):120-7. PubMed ID: 1061638 [TBL] [Abstract][Full Text] [Related]
18. Terminal deoxynucleotidyl transferase activity in childhood leukemia. Winick N; Steinherz PG; Miller DR Cancer; 1985 May; 55(9):1943-7. PubMed ID: 3978575 [TBL] [Abstract][Full Text] [Related]
19. Terminal deoxynucleotidyl transferase, TdT, as a marker for leukemia and lymphoma cells. Campagnari F; Bombardieri E; de Braud F; Baldini L; Maiolo AT Int J Biol Markers; 1987; 2(1):31-42. PubMed ID: 3323341 [TBL] [Abstract][Full Text] [Related]
20. Proliferation of normal and leukemic TdT+ bone marrow cells in man. Hirt A; Wagner HP Leuk Res; 1982; 6(2):149-53. PubMed ID: 6964368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]